US FTC sues to block Illumina/Pacific Biosciences

Pallavi Guniganti and Charles McConnell

18 December 2019

The US Federal Trade Commission has issued an administrative complaint alleging that a merger in the DNA sequencing industry will maintain Illumina’s monopoly by eliminating a nascent competitive threat.

Subscribe to Global Competition Review

Subscribe and start reading now

Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.

Subscribe now

Already have access? Login below

Pallavi Guniganti

View full biography

Author

[email protected]

Charles McConnell